Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Brain tumor, child: Brain stem glioma
Stage/Subtype:  untreated childhood brain stem glioma
Trial Type:  Treatment
Results 1-7 of 7 for your search:
Start Over
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Any age
Trial IDs: 05-122, NCI-2016-00874, MSKCC-05122, NCT00445965
Valproic Acid and Radiation Therapy Followed by Maintenance Valproic Acid and Bevacizumab in Treating Young Patients With Newly Diagnosed High-Grade Gliomas
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 3 to 21
Trial IDs: H-24549, NCI-2012-00618, NCT00879437
Proton Beam Radiation Therapy in Treating Younger Patients with Brain Tumors
Status: Active
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Age: 1 to 25
Trial IDs: 10-206, NCI-2011-00201, NCT01288235
Lenalidomide and Radiation Therapy in Treating Children with Pontine Glioma or High-Grade Glioma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Under 19 at diagnosis
Trial IDs: 8449, NCI-2011-02539, CDR0000687467, NCI-10-C-0219, P10687, 100219, 10-C-0219, NCT01226940
WEE1 Inhibitor MK-1775 and Local Radiation Therapy in Treating Younger Patients with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 37 months to 21 years
Trial IDs: ADVL1217, NCI-2013-01602, COG-ADVL1217, NCT01922076
HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine and Poly-ICLC in Treating Children with Newly Diagnosed High-Grade Glioma, Brainstem Glioma, or Recurrent Unresectable Low-Grade Glioma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 19 months to 20 years
Trial IDs: Glioma Vaccine, NCI-2016-00993, NCT01130077
Molecular Profiling in Planning Cancer Treatment in Younger Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 25 and under
Trial IDs: 14082, NCI-2015-01136, PNOC 003, 139939, NCT02274987
Start Over